Schrödinger faces financial losses amid investment in experimental drugs. Key 2025 trial results will reveal its future ...

TORONTO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company ...

Review of data from the trial found that the vaccine was not sufficiently effective at preventing invasive E coli disease ...

Gene Mack, Gain Therapeutics CEO, provides a look into the future of the company and the use of physics-based artificial ...

New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and ...

After weeks of disruption to scientific federal grants, the National Institutes of Health has fallen behind in funding ...

A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

Positive IHL-42X PK findings for the treatment of Obstructive Sleep Apnea (OSA) support future 505(b)(2) New Drug Application (NDA) submissionNew OSA Clinical Advisory Board Announced; Appoints Dr. Al ...

The American Cancer Society's chief scientific officer outlines the group's research agenda, including a new project in ...

Positve overall survival data could lead to a label expansion for Pfizer's combination to treat metastatic ...

EXCLUSIVE: Retired David Mather was dealt a shocking blow when told his tiredness was stage-IV lung cancer - now a new UK ...